These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 5426933
1. Urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in female Swiss mice. Ertürk E, Cohen SM, Bryan GT. Cancer Res; 1970 May; 30(5):1309-11. PubMed ID: 5426933 [No Abstract] [Full Text] [Related]
2. Comparative carcinogenicity in Swiss mice of N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide and structurally related 5-nitrofurans and 4-nitrobenzenes. Cohen SM, Lower GM, Ertürk E, Bryan GT. Cancer Res; 1973 Jul; 33(7):1593-7. PubMed ID: 4721223 [No Abstract] [Full Text] [Related]
3. Carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]-hydrazide in Swiss mice. Cohen SM, Ertürk E, Bryan GT. Cancer Res; 1970 Apr; 30(4):906-12. PubMed ID: 4324549 [No Abstract] [Full Text] [Related]
6. Comparative urinary and gallbladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide and N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide in the dog. Ertürk E, Atassi SA, Yoshida O, Cohen SM, Price JM, Bryan GT. J Natl Cancer Inst; 1970 Sep; 45(3):535-42. PubMed ID: 4331642 [No Abstract] [Full Text] [Related]
8. Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms. Daskal Y, Soloway MS, DeFuria MD, Crooke ST. Cancer Res; 1980 Feb; 40(2):261-7. PubMed ID: 7356509 [Abstract] [Full Text] [Related]
9. The effect of gonadectomy and hormone administration on the urinary bladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide in male and female Swiss mice. Yoshida O, Ertürk E, Bryan GT, Lower GM. Invest Urol; 1973 Nov; 11(3):216-20. PubMed ID: 4749422 [No Abstract] [Full Text] [Related]
10. Malignant transformation of urinary bladder in humans and in N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-exposed Fischer rats: ultrastructure of the major components of the permeability barrier. Merk FB, Pauli BU, Jacobs JB, Alroy J, Friedell GH, Weinstein RS. Cancer Res; 1977 Aug; 37(8 Pt 2):2843-53. PubMed ID: 872113 [No Abstract] [Full Text] [Related]
11. Pathogenesis, histology, and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide. Ertürk E, Cohen SM, Price JM, Bryan GT. Cancer Res; 1969 Dec; 29(12):2219-28. PubMed ID: 5387262 [No Abstract] [Full Text] [Related]
16. Ultrastructure and reversibility of bladder carcinoma of rats produced by feeding of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide. Pai SH, Amaral L, Werthamer S, Zak FG. Invest Urol; 1973 Sep; 11(2):125-35. PubMed ID: 4728260 [No Abstract] [Full Text] [Related]
17. The production of carcinoma of the urinary bladder in rats by feeding N-[3-(5-nitro-2-furyl)-2-thiazolyl]formamide. Ertürk E, Price JM, Morris JE, Cohen S, Leith RS, Von Esch AM, Crovetti AJ. Cancer Res; 1967 Nov; 27(11):1998-2002. PubMed ID: 6073497 [No Abstract] [Full Text] [Related]
18. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats. Grossman HB, Sonda LP, Lesser ML. Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579 [Abstract] [Full Text] [Related]
19. Low susceptibility of analbuminemic rats to induction of bladder cancer by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Hosaka Y, Muramatsu M, Matsushima T, Niijima T, Nagase S. Jpn J Cancer Res; 1985 Jul; 76(7):577-82. PubMed ID: 3928553 [Abstract] [Full Text] [Related]
20. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats. Rice JR, Spry LA, Zenser TV, Davis BB. Cancer Res; 1988 Jan 15; 48(2):304-9. PubMed ID: 3121171 [Abstract] [Full Text] [Related] Page: [Next] [New Search]